The study results show exciting immune responses in patients with operable esophageal or gastroesophageal cancers given neoadjuvant immunotherapy and highlight the potential for monitoring circulating tumor DNA as a predictor for future intervention.
After more than 18 months of working to meet the criteria to become an authorized treatment center,
Baylor University Medical Center is poised to be one of the first in the nation to offer a newly FDA-approved tumor-infiltrating lymphocytes (TIL) cellula
...
Baylor Scott & White The Heart Hospital – Plano* has earned the highest quality rating in all five surgical categories from The Society of Thoracic Surgeons (STS), placing the hospital’s performance among the top 1% in the nation for cardiac surgery.
Baylor Scott & White Heart and Vascular Hospital – Dallas has added an innovative, minimally invasive option for patients with hypertension, or high blood pressure.
Baylor Scott & White Health once again leads the state of Texas in the number of accolades earned in U.S. News & World Report's 2023-24 Best Hospitals, released today.
Baylor Scott & White Heart and Vascular Hospital – Waxahachie*, an expansion of the nationally recognized Baylor Scott & White Heart and Vascular Hospital – Dallas*, is now complete.